Amgen Inc. Acquisitions, Net of Cash Acquired
Amgen Inc. (AMGN) reported Acquisitions, Net of Cash Acquired of $53.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-02-13
- Amgen Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2022-12-31 was $3.84B, a 331.35% increase year-over-year.
- Amgen Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Amgen Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-12-31 was $890.00M.
- Amgen Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2021-09-30 was $13.00M.
- Amgen Inc. payments to acquire businesses, net of cash acquired for fiscal 2025 was $53.00M.
- Amgen Inc. payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Amgen Inc. payments to acquire businesses, net of cash acquired for fiscal 2023 was $26.99B, a 603.02% increase from fiscal 2022.
- Amgen Inc. payments to acquire businesses, net of cash acquired for fiscal 2022 was $3.84B, a 51.80% increase from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $53.00M 10-K · filed 2026-02-13 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-13 | ||||
| 2023-12-31 | $26.99B 10-K · filed 2026-02-13 | ||||
| 2022-12-31 | $3.84B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $3.84B derived: sum of 2 quarters · filed 2025-02-14 | $3.84B 10-K · filed 2025-02-14 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 | ||||
| 2021-12-31 | $890.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $903.00M derived: sum of 2 quarters · filed 2024-02-14 | $2.53B 10-K · filed 2024-02-14 | ||
| 2021-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.64B 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | $1.63B 10-Q · filed 2022-08-05 | -$1.63B 10-Q · filed 2021-08-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-K · filed 2023-02-09 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | ||||
| 2019-12-31 | $13.44B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $13.62B derived: sum of 2 quarters · filed 2022-02-16 | $13.62B derived: sum of 3 quarters · filed 2022-02-16 | $13.62B 10-K · filed 2022-02-16 | |
| 2019-09-30 | $177.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $177.00M derived: sum of 2 quarters · filed 2019-10-30 | $177.00M 10-Q · filed 2019-10-30 | $179.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $0.00 10-Q · filed 2019-07-31 | $2.00M derived: sum of 3 quarters · filed 2021-02-09 | $2.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $2.00M derived: sum of 2 quarters · filed 2021-02-09 | $2.00M derived: sum of 3 quarters · filed 2021-02-09 | $2.00M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2018-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $2.00M derived: sum of 2 quarters · filed 2021-02-09 | $2.00M derived: sum of 3 quarters · filed 2021-02-09 | -$195.00M 10-K · filed 2021-02-09 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | -$197.00M 10-Q · filed 2019-10-30 | -$178.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$197.00M 10-Q · filed 2019-07-31 | -$178.00M derived: sum of 3 quarters · filed 2020-02-12 | -$178.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-03-31 | -$197.00M 10-Q · filed 2019-05-01 | -$178.00M derived: sum of 2 quarters · filed 2020-02-12 | -$178.00M derived: sum of 3 quarters · filed 2020-02-12 | -$178.00M derived: sum of 4 quarters · filed 2020-02-12 | |
| 2017-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $19.00M derived: sum of 2 quarters · filed 2020-02-12 | $19.00M derived: sum of 3 quarters · filed 2020-02-12 | $19.00M 10-K · filed 2020-02-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $0.00 derived: sum of 2 quarters · filed 2018-10-31 | $0.00 10-Q · filed 2018-10-31 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $0.00 10-Q · filed 2018-07-27 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-25 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-13 | ||||
| 2015-12-31 | $359.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $359.00M derived: sum of 2 quarters · filed 2018-02-13 | $359.00M derived: sum of 3 quarters · filed 2018-02-13 | $359.00M 10-K · filed 2018-02-13 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 derived: sum of 2 quarters · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | $50.00M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | $50.00M derived: sum of 3 quarters · filed 2017-02-14 | $50.00M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-04-27 | $50.00M derived: sum of 2 quarters · filed 2017-02-14 | $50.00M derived: sum of 3 quarters · filed 2017-02-14 | $61.00M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2014-12-31 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $50.00M derived: sum of 2 quarters · filed 2017-02-14 | $61.00M derived: sum of 3 quarters · filed 2017-02-14 | $165.00M 10-K · filed 2017-02-14 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $11.00M derived: sum of 2 quarters · filed 2015-11-02 | $115.00M 10-Q · filed 2015-11-02 | $9.55B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-06-30 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $115.00M 10-Q · filed 2015-08-05 | $9.55B derived: sum of 3 quarters · filed 2016-10-31 | $9.55B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2014-03-31 | $104.00M 10-Q · filed 2015-04-27 | $9.54B derived: sum of 2 quarters · filed 2016-10-31 | $9.54B derived: sum of 3 quarters · filed 2016-10-31 | $9.54B derived: sum of 4 quarters · filed 2016-10-31 | |
| 2013-12-31 | $9.43B derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $9.43B derived: sum of 2 quarters · filed 2016-10-31 | $9.43B derived: sum of 3 quarters · filed 2016-10-31 | $9.43B 8-K · filed 2016-10-31 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $0.00 derived: sum of 2 quarters · filed 2014-10-29 | $0.00 10-Q · filed 2014-10-29 | $400.00M derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 | $400.00M derived: sum of 3 quarters · filed 2015-02-19 | $719.00M derived: sum of 4 quarters · filed 2015-02-19 | |
| 2013-03-31 | $0.00 10-Q · filed 2014-04-30 | $400.00M derived: sum of 2 quarters · filed 2015-02-19 | $719.00M derived: sum of 3 quarters · filed 2015-02-19 | $1.42B derived: sum of 4 quarters · filed 2015-02-19 | |
| 2012-12-31 | $400.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $719.00M derived: sum of 2 quarters · filed 2015-02-19 | $1.42B derived: sum of 3 quarters · filed 2015-02-19 | $2.39B 10-K · filed 2015-02-19 | |
| 2012-09-30 | $319.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $1.02B derived: sum of 2 quarters · filed 2013-10-29 | $1.99B 10-Q · filed 2013-10-29 | $1.99B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-06-30 | $702.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $1.67B 10-Q · filed 2013-08-06 | $1.67B derived: sum of 3 quarters · filed 2014-02-24 | $1.67B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2012-03-31 | $969.00M 10-Q · filed 2013-05-03 | $969.00M derived: sum of 2 quarters · filed 2014-02-24 | $969.00M derived: sum of 3 quarters · filed 2014-02-24 | $1.27B derived: sum of 4 quarters · filed 2014-02-24 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $0.00 derived: sum of 2 quarters · filed 2014-02-24 | $298.00M derived: sum of 3 quarters · filed 2014-02-24 | $701.00M 10-K · filed 2014-02-24 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $298.00M derived: sum of 2 quarters · filed 2012-11-06 | $701.00M 10-Q · filed 2012-11-06 | $701.00M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-06-30 | $298.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $701.00M 10-Q · filed 2012-08-08 | $701.00M derived: sum of 3 quarters · filed 2013-02-27 | $701.00M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-31 | $403.00M 10-Q · filed 2012-05-08 | $403.00M derived: sum of 2 quarters · filed 2013-02-27 | $403.00M derived: sum of 3 quarters · filed 2013-02-27 | $403.00M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $0.00 derived: sum of 3 quarters · filed 2013-02-27 | $0.00 10-K · filed 2013-02-27 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $0.00 derived: sum of 2 quarters · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | $0.00 derived: sum of 4 quarters · filed 2012-02-29 | |
| 2010-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $0.00 10-Q · filed 2011-08-08 | $0.00 derived: sum of 3 quarters · filed 2012-02-29 | ||
| 2010-03-31 | $0.00 10-Q · filed 2011-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-02-29 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $0.00 10-K · filed 2012-02-29 | |||
| 2009-09-30 | $0.00 10-Q · filed 2009-11-06 | ||||
| 2008-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $56.00M 10-K · filed 2011-02-25 | |||
| 2008-09-30 | $50.00M 10-Q · filed 2009-11-06 | ||||
| 2007-12-31 | $697.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |